Patent directory · USPTO A61K / A61P
Patents matching “antagonist”
678 pharma patents match "antagonist" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 678 pharmaceutical patents matching "antagonist" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10626146
α4β7 thioether peptide dimer antagonists
granted -
CA 3112060
COMPOSITION PHARMACEUTIQUE COMPRENANT UN ANTAGONISTE DE GPRP RADIOMARQUE ET UN TENSIOACTIF
granted -
US 10617673
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted -
US 10610534
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
granted -
US 10604507
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
granted -
US 10597448
Methods for treating visceral pain associated with interstitial cystitis by administering antagonist antibodies directed against calcitonin gene-related peptide
granted -
US 10590107
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
granted -
US 10577361
Dopamine D3 receptor antagonists having a morpholine moiety
granted -
US 10570092
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 10562884
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
granted -
US 10556945
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
granted -
US 10544188
Inhibitor of apoptosis protein (IAP) antagonists
granted -
US 10538530
Vasopressin receptor antagonists and products and methods related thereto
granted -
US 10532096
Methods and compositions comprising a combination of a VEGF antagonist and an anti-CTLA-4 antibody
granted -
CA 3105778
POLYTHERAPIE AVEC DES ANTAGONISTES DU CGRP ET DES DERIVES DE CLOSTRIDIUM
granted -
US 10508103
Benzimidazole-linked indole compound acting as novel divalent IAP antagonist
granted -
US 10464992
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 10456380
Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists
granted -
US 10407468
Methods for synthesizing α4β7 peptide antagonists
granted -
US 10407443
5-HT3 receptor antagonists
granted -
US 10406226
Method of manufacturing VEGF antagonist fusion proteins
granted -
US 10400025
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 10377751
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
granted -
US 10369142
Combination dosage form of a mu opioid receptor antagonist and an opioid agent
granted